Karen L. Zaderej Eye Point Pharmaceuticals, Inc. (EYPT) insider trading activity

Karen L. Zaderej is of EyePoint Pharmaceuticals, Inc.. Currently has a direct ownership of 38,500 shares of EYPT, which is worth approximately $413,875. The most recent transaction as insider was on Jul 11, 2025, when has been sold 2,000 shares (Common Stock) at a price of $0.0 per share, resulting in proceeds of $0. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 38.5K

22.22% 3M change

862.5% 12M change

Total Value Held $413,875

Karen L. Zaderej Transaction History

Date	Transaction	Value	Shares Traded	Shares Held
Jul 11 2025	BUY Exercise of conversion of derivative security	-	2,000 Added 4.94%	38,500 Common Stock
May 19 2025	BUY Open market or private purchase	$29,950 $5.99 p/Share	5,000 Added 12.05%	36,500 Common Stock
May 16 2025	BUY Open market or private purchase	$29,049 $5.81 p/Share	5,000 Added 13.7%	31,500 Common Stock
May 15 2025	BUY Open market or private purchase	$27,350 $5.47 p/Share	5,000 Added 15.87%	26,500 Common Stock
May 14 2025	BUY Open market or private purchase	$27,100 $5.42 p/Share	5,000 Added 18.87%	21,500 Common Stock
Aug 19 2024	BUY Open market or private purchase	$99,750 $7.98 p/Share	12,500 Added 43.1%	16,500 Common Stock
Jul 11 2024	BUY Exercise of conversion of derivative security	-	2,000 Added 33.33%	4,000 Common Stock
Jul 11 2023	BUY Exercise of conversion of derivative security	-	2,000 Added 50.0%	2,000 Common Stock

Also insider at

AXGN

Axogen, Inc. Healthcare

CEO

KLZ

Karen L. Zaderej

Watertown, MA

Institutional Portfolio Updates

Receive a notification when an Institution or Guru buys or sells EYPT shares.

Notify only if

Value

Insider Trading

Get notified when an Eye Point Pharmaceuticals, Inc. insider buys or sells EYPT shares.

Notify only if

Operation

Value

Type

News

Receive news related to EyePoint Pharmaceuticals, Inc.

Track Activities on EYPT

Account